Neuralink, the brain-computer company founded by Elon Musk, achieved a significant milestone as it successfully implanted a device in a live human patient for the first time. Musk reported that the patient is recovering well, and the data from the implant shows promise. This development comes after U.S. authorities granted approval for human clinical trials following controversial animal tests. While Neuralink faced scrutiny and a federal probe related to animal tests, it is positioned as a frontrunner among several companies working on human brain implants, with its technology offering greater precision and potential for extensive external communication based solely on thoughts.